| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 5.813 | 20101214, Gadisseur R
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 2.620 | 20100301, Scala E
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 2.860 | 20130605, Simon D
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 2.080 | 20120528, Patelis A
| | 1.4 - Respiratory Symptoms, Diagnosed | 2014 | Austria | IgE | 42 | 10.000 | 20140707, Banerjee S
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Austria | IgE | 5 | 67.000 | 20140707, Banerjee S
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Germany | IgE | 100 | 25.000 | 20140707, Banerjee S
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 2.140 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 20.000 | 20091005, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 8.000 | 20140821, Choi JS
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 3.2.1 - Source Sensitized (IgE) | 2003 | Austria | IgE | 20 | 10.000 | | | 3.2.1 - Source Sensitized (IgE) | 2003 | Zimbabwe | IgE | 20 | 55.000 | | | 3.2.1 - Source Sensitized (IgE) | 1998 | Spain | IgE (IB) | 71 | 5.600 | | | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 13.640 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2014 | Singapore | IgE | 38 | 31.600 | 20140926, Thalayasingam M
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2008 | Sweden | IgE | 31 | 3.000 | 20081121, Weghofer M
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2014 | Singapore | IgE | 27 | 14.800 | 20140926, Thalayasingam M
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 36 | 66.660 | 20110609, Gamez C
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 9 | 0.000 | 20110609, Gamez C
| | 5.1.1 - Source Exposed (Symptoms) | 2013 | Germany | IgE | 98 | 4.080 | 20130501, Becker S
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2004 | Australia / Austria | IgE | 78 | 6.400 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 48 | 2.200 | 20141122, Morales M
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 45 | 4.700 | 20141122, Morales M
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 43 | 4.700 | 20141122, Morales M
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 33 | 0.000 | 20141122, Morales M
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2011 | Spain | IgE | 40 | 0.000 | 20110228, Boquete M
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2011 | Spain | IgE | 25 | 32.000 | 20110228, Boquete M
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2006 | Australia | IgE | 105 | 8.600 | 20060524, Hales BJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2006 | Australia | IgE | 77 | 28.600 | 20060524, Hales BJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Austria | IgE | 56 | 18.000 | 20081121, Weghofer M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 5.050 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2007 | Colombia | IgE | 90 | 16.700 | 20080220, Jimenez S
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | France | IgE | 55 | 9.000 | 20081121, Weghofer M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Italy | IgE | 67 | 10.000 | 20081121, Weghofer M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Singapore | IgE | 38 | 21.100 | 20140926, Thalayasingam M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Sweden | IgE | 65 | 18.000 | 20081121, Weghofer M
| | 5.3.2 - Source Exposed (Symptoms, high IgE) | 2012 | France | IgE | 123 | 27.640 | 20120521, Bronnert M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Austria | IgE | 1322 | 15.200 | 20110629, Resch Y
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | France | IgE | 19 | 10.530 | 20120622, Casset A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Italy | IgE | 26 | 19.230 | 20120622, Casset A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Singapore | IgE | 225 | 7.000 | 20110221, Kidon MI
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.810 | 20120528, Patelis A
|
|
Loading...
Der p 10
